|
ID |
Virus |
Mutation |
Gene |
Disease |
Score |
Significance |
Detail
|
1 |
EBV |
G155391A |
RPMS1 |
Nasopharyngeal carcinoma |
24.394 |
***
|
View |
2 |
EBV |
V29A |
BARF1 |
Nasopharyngeal carcinoma |
7.849 |
***
|
View |
3 |
EBV |
I152L |
LMP1 |
Hodgkin lymphoma |
7.782 |
***
|
View |
4 |
EBV |
I124V |
LMP1 |
Hodgkin lymphoma |
7.014 |
***
|
View |
5 |
EBV |
L151I |
LMP1 |
Hodgkin lymphoma |
6.362 |
***
|
View |
6 |
EBV |
F144I |
LMP1 |
Hodgkin lymphoma |
5.559 |
***
|
View |
7 |
EBV |
V1222I |
BNRF1 |
Nasopharyngeal carcinoma |
4.942 |
***
|
View |
8 |
EBV |
G155391A |
RPMS1 |
EBV-related malignancy |
4.046 |
***
|
View |
9 |
EBV |
I438L |
EBNA2 |
Nasopharyngeal carcinoma |
3.802 |
***
|
View |
10 |
EBV |
E476G |
EBNA2 |
Nasopharyngeal carcinoma |
3.802 |
***
|
View |
11 |
EBV |
P484H |
EBNA2 |
Nasopharyngeal carcinoma |
3.802 |
***
|
View |
12 |
EBV |
I486T |
EBNA2 |
Nasopharyngeal carcinoma |
3.802 |
***
|
View |
13 |
EBV |
D150A |
LMP1 |
Hodgkin lymphoma |
3.324 |
***
|
View |
14 |
EBV |
T165545C |
BARF1 |
Nasopharyngeal carcinoma |
3.101 |
***
|
View |
15 |
EBV |
H130R |
BARF1 |
Nasopharyngeal carcinoma |
3.088 |
***
|
View |
16 |
EBV |
Q322N |
LMP1 |
Hodgkin disease |
2.96 |
***
|
View |
17 |
EBV |
V29A |
BARF1 |
Gastric carcinoma |
2.774 |
***
|
View |
18 |
EBV |
del 49102 |
EBNA2Â |
Lymphoproliferative disease |
2.659 |
***
|
View |
19 |
EBV |
Q322X |
LMP1 |
Diffuse large B cell lymphomas |
2.184 |
***
|
View |
20 |
EBV |
G342X |
LMP1 |
Diffuse large B cell lymphomas |
2.184 |
***
|
View |
21 |
EBV |
V317M |
BALF2 |
Nasopharyngeal carcinoma |
2.139 |
***
|
View |
22 |
EBV |
F151L |
BARF1 |
NK/T-cell lymphoma |
2.115 |
***
|
View |
23 |
EBV |
A49137G |
EBNA2 |
Squamous cell carcinoma of head and neck |
2.059 |
***
|
View |
24 |
EBV |
H352R |
LMP1 |
Burkitt lymphoma |
2.058 |
***
|
View |
25 |
EBV |
del30 |
LMP1 |
Lymphoma |
1.96 |
*
|
View |
26 |
EBV |
I150A |
LMP1 |
Hodgkin lymphoma |
1.96 |
*
|
View |
27 |
EBV |
G48991T |
EBNA2 |
Lymphoma |
1.884 |
*
|
View |
28 |
EBV |
C48998A |
EBNA2 |
Lymphoma |
1.884 |
*
|
View |
29 |
EBV |
T49613A |
EBNA2 |
Burkitt lymphoma |
1.883 |
*
|
View |
30 |
EBV |
P291T |
EBNA2 |
Nasopharyngeal carcinoma |
1.805 |
*
|
View |
31 |
EBV |
R413G |
EBNA2 |
Nasopharyngeal carcinoma |
1.794 |
*
|
View |
32 |
EBV |
G696R |
BNRF1 |
Nasopharyngeal carcinoma |
1.793 |
*
|
View |
33 |
EBV |
C48998A |
EBNA2 |
EBV-HIV coinfections |
1.788 |
*
|
View |
34 |
EBV |
C48998A |
EBNA2 |
Squamous cell carcinoma of head and neck |
1.788 |
*
|
View |
35 |
EBV |
R163M |
EBNA2 |
EBV-HIV coinfections |
1.787 |
*
|
View |
36 |
EBV |
R163M |
EBNA2 |
Squamous cell carcinoma of head and neck |
1.787 |
*
|
View |
37 |
EBV |
Q322X |
LMP1 |
NK/T-cell lymphoma |
1.759 |
*
|
View |
38 |
EBV |
G342X |
LMP1 |
NK/T-cell lymphoma |
1.759 |
*
|
View |
39 |
EBV |
V79L |
BHRF1 |
NK/T-cell lymphoma |
1.759 |
*
|
View |
40 |
EBV |
L150I |
LMP1 |
Hodgkin lymphoma |
1.662 |
*
|
View |
41 |
EBV |
E377A |
BRLF1 |
Gastric carcinoma |
1.587 |
*
|
View |
42 |
EBV |
T165589C |
BARF1 |
NK/T-cell lymphoma |
1.585 |
*
|
View |
43 |
EBV |
D51E |
RPMS1 |
Nasopharyngeal carcinoma |
1.514 |
*
|
View |
44 |
EBV |
F144I |
LMP1 |
Ovarian epithelial carcinoma |
1.477 |
*
|
View |
45 |
EBV |
T49613A |
EBNA2 |
Gastric carcinoma |
1.464 |
*
|
View |
46 |
EBV |
H130R |
BARF1 |
Lymphoproliferative disease |
1.451 |
*
|
View |
47 |
EBV |
G48991T |
EBNA2 |
Gastric carcinoma |
1.37 |
*
|
View |
48 |
EBV |
C48998A |
EBNA2 |
Gastric carcinoma |
1.37 |
*
|
View |
49 |
EBV |
del30 |
LMP1 |
Hodgkin lymphoma |
1.314 |
*
|
View |
50 |
EBV |
L88V |
BHRF1 |
NK/T-cell lymphoma |
1.289 |
ns |
View |
51 |
EBV |
L88V |
BHRF1 |
Gastric carcinoma |
1.282 |
ns |
View |
52 |
EBV |
T165545C |
BARF1 |
NK/T-cell lymphoma |
1.223 |
ns |
View |
53 |
EBV |
F144I |
LMP1 |
EBV-HIV coinfections |
1.197 |
ns |
View |
54 |
EBV |
C48998A |
EBNA2 |
Nasopharyngeal carcinoma |
1.162 |
ns |
View |
55 |
EBV |
A206S |
BZLF1 |
Nasopharyngeal carcinoma |
1.133 |
ns |
View |
56 |
EBV |
A7048C |
BALF2 |
Nasopharyngeal carcinoma |
1.133 |
ns |
View |
57 |
EBV |
S12T |
BARF1 |
Nasopharyngeal carcinoma |
1.127 |
ns |
View |
58 |
EBV |
S128F |
BARF1 |
Nasopharyngeal carcinoma |
1.127 |
ns |
View |
59 |
EBV |
K316E |
BRLF1 |
Gastric carcinoma |
1.12 |
ns |
View |
60 |
EBV |
V29A |
BARF1 |
Lymphoproliferative disease |
0.973 |
ns |
View |
61 |
EBV |
G155391A |
RPMS1 |
Burkitt lymphoma |
0.785 |
ns |
View |
62 |
EBV |
R179A |
BZLF1 |
EBV infections |
0.746 |
ns |
View |
63 |
EBV |
E377A |
BRLF1 |
Nasopharyngeal carcinoma |
0.683 |
ns |
View |
64 |
EBV |
W72G |
BARF1 |
Nasopharyngeal carcinoma |
0.683 |
ns |
View |
65 |
EBV |
G50134C |
EBNA1 |
Nasopharyngeal carcinoma |
0.683 |
ns |
View |
66 |
EBV |
G342X |
LMP1 |
Nasopharyngeal carcinoma |
0.683 |
ns |
View |
67 |
EBV |
Q322X |
LMP1 |
Nasopharyngeal carcinoma |
0.683 |
ns |
View |
68 |
EBV |
C11404T |
EBNA1 |
Nasopharyngeal carcinoma |
0.683 |
ns |
View |
69 |
EBV |
F144I |
LMP1 |
NK/T-cell lymphoma |
0.674 |
ns |
View |
70 |
EBV |
Y180E |
BZLF1 |
EBV infections |
0.656 |
ns |
View |
71 |
EBV |
V29A |
BARF1 |
NK/T-cell lymphoma |
0.647 |
ns |
View |
72 |
EBV |
S186A |
BZLF1 |
EBV infections |
0.584 |
ns |
View |
73 |
EBV |
T49613A |
EBNA2 |
Nasopharyngeal carcinoma |
0.574 |
ns |
View |
74 |
EBV |
G155391A |
RPMS1 |
Gastric carcinoma |
0.572 |
ns |
View |
75 |
EBV |
G155391A |
RPMS1 |
NK/T-cell lymphoma |
0.57 |
ns |
View |
76 |
EBV |
C189S |
BZLF1 |
Burkitt lymphoma |
0.513 |
ns |
View |
77 |
EBV |
G48991T |
EBNA2 |
Nasopharyngeal carcinoma |
0.493 |
ns |
View |
78 |
EBV |
R163M |
EBNA2 |
Nasopharyngeal carcinoma |
0.492 |
ns |
View |
79 |
EBV |
G155391A |
RPMS1 |
Hodgkin lymphoma |
0.478 |
ns |
View |
80 |
EBV |
L88V |
BHRF1 |
Nasopharyngeal carcinoma |
0.382 |
ns |
View |
81 |
EBV |
K316E |
BRLF1 |
Nasopharyngeal carcinoma |
0.298 |
ns |
View |
82 |
EBV |
F144I |
LMP1 |
Nasopharyngeal carcinoma |
0.143 |
ns |
View |
|
|
Contents Description
Histogram Chart or Table Note
* Virus: Virus name
* Mutation: Virus mutation
* Gene: Virus gene
* Disease: Related disease
* Significant: ***, p < 0.001; **, p < 0.01; *, p < 0.05; ns, not significant
* Score: The -log10(p value) of co-occurrence correlation of the mutation and disease in sentences by Fisher's test
|